In summary, the serum levels of miR-21, HSP90α, and GASP-1 are elevated in patients with lung cancer, and the levels are associated with the pathological subtypes, staging, and lymph node metastasis of the patients. This evidence concerns the gene HSP90AA1 and metastatic malignant neoplasm in the lymph nodes.